Alex Karlsson-Parra
Founder presso MENDUS AB
Patrimonio netto: 28 411 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Alex Karlsson-Parra
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
35
| Public Company | Biotechnology | 35 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alex Karlsson-Parra tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CREATIVE ANTIBIOTICS SWEDEN AB | Pharmaceuticals: Major | Director/Board Member | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Director of Finance/CFO | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| ALLENEX AB | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| Handelshögskolan i Göteborg | College/University | Undergraduate Degree Masters Business Admin | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ceradis BV
 Ceradis BV Chemicals: AgriculturalProcess Industries Ceradis BV develops and markets environmental solutions for plant nutrition, crop protection, and formulation services. It focuses on the use of biological formulation additives and the development of biofungicides based on macro-organisms or natural products. The company was founded by Wim M. van der Krieken in 2005 and is headquartered in Wageningen, the Netherlands. | Chemicals: Agricultural | Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
Medis Medical Imaging Systems BV
 Medis Medical Imaging Systems BV Packaged SoftwareTechnology Services Medis Medical Imaging Systems BV engages in the development and supply of software solutions for data imaging used by medical industry. Its products include Media Suite MR, Media Suite XA, Medis Suite CT, and Intravascular. The company was founded by Johan Hans C. Reiber in 1989 and is headquartered in Leiden, the Netherlands. | Packaged Software | Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Chalmers School of Entrepreneurship | College/University | Graduate Degree Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| IDOGEN AB (PUBL) | Biotechnology | Sales & Marketing Chairman Director/Board Member | |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
Sensara BV
 Sensara BV Internet Software/ServicesTechnology Services Sensara BV engages in the development of self-learning, intelligent home monitoring solutions for the home care industry. It offers a smart sensor system, which detects unusual situations and sounds an alarm when something is wrong. The company was founded by Irek Karkowski and Ted Punt and is headquartered in Rotterdam, the Netherlands. | Internet Software/Services | Director/Board Member | |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chairman | |
| Anemones Hospitality & Hotels Pvt Ltd. | Director/Board Member | ||
| ELICERA THERAPEUTICS AB | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director/Board Member General Counsel | |
| Centre For Advanced Medical Products | Director/Board Member Director/Board Member | ||
Pan Cancer T
 Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Miscellaneous | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Svezia | 28 |
| Paesi Bassi | 15 |
| Stati Uniti | 4 |
| Danimarca | 3 |
| Francia | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 172 |
| Corporate Officer/Principal | 96 |
| Chairman | 53 |
| Chief Executive Officer | 52 |
| Independent Dir/Board Member | 46 |
Contatti più connessi
- Borsa valori
- Insiders
- Alex Karlsson-Parra
- Connessioni Società
